A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
Clinical trial NCT06672055 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06672055
- Sponsor
- Vaxart
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2027-05-01
- Enrollment
- 5485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.